Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)
Others
Ratios

BioLineRx (BLRX) Gross Profit (2024 - 2025)

Historic Gross Profit for BioLineRx (BLRX) over the last 2 years, with Q3 2025 value amounting to $343000.0.

  • BioLineRx's Gross Profit fell 9167.68% to $343000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $6.5 million, marking a year-over-year decrease of 5394.16%. This contributed to the annual value of $19.7 million for FY2024, which is 167590.25% up from last year.
  • Per BioLineRx's latest filing, its Gross Profit stood at $343000.0 for Q3 2025, which was down 9167.68% from $232000.0 recorded in Q2 2025.
  • Over the past 5 years, BioLineRx's Gross Profit peaked at $5.7 million during Q4 2024, and registered a low of $221000.0 during Q1 2025.